申请人:Sova Pharmaceuticals, Inc.
公开号:US20170327478A1
公开(公告)日:2017-11-16
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.